0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Brief Communications |

Temporary Discontinuation of Warfarin Therapy: Changes in the International Normalized Ratio

Richard H. White, MD; Tara McKittrick, MS; Rose Hutchinson, MS, FNP; and Jeff Twitchell, MD
[+] Article and Author Information

From the University of California, Davis, California. Requests for Reprints: Richard H. White, MD, Room 3107 PCC, 2221 Stockton Boulevard, Sacramento, CA 95817. Acknowledgments: The authors thank Dr. Stephen McCurdy for his careful and thorough review of the manuscript.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1995;122(1):40-42. doi:10.7326/0003-4819-122-1-199501010-00006
Text Size: A A A

Objective: To measure the rate of decrease of the international normalized ratio (INR) after temporary discontinuation of warfarin therapy.

Design: Prospective evaluation of an outpatient cohort.

Setting: University medical center anticoagulation clinic.

Patients: 22 patients receiving a fixed evening dose of warfarin for whom temporary discontinuation of therapy was deemed safe.

Measurements: Serial plasma samples were drawn for INR measurements approximately 20, 65, 115, and 185 hours after patients received the last dose of warfarin. In five patients, INR was measured twice daily for 5 days.

Results: For patients with a mean steady-state INR of 2.6, the mean INR 65 hours (2.7 days) after discontinuation of warfarin therapy was 1.6 (range, 1.11 to 2.16); 20 of 22 patients (91%) had an INR greater than 1.2. The mean INR 115 hours (4.7 days) after discontinuation of warfarin therapy was 1.1; 5 of 22 patients (23%) had an INR of 1.2 or greater. In 5 patients studied in detail, the INR decreased exponentially and had a half-life that ranged from 0.52 to 1.2 days; the onset of maximal decrease began 24 to 36 hours after discontinuation of warfarin therapy. In the total cohort, age was a significant (P < 0.005) independent predictor of smaller decreases in the INR between day 1 and day 3 (regression coefficient = −6.8% ± 2%/2 days per decade of age; R2 = 0.34).

Conclusions: By simulating preoperative discontinuation of warfarin therapy, we found that the INR decreases exponentially, with wide interpatient variation in the rate of decrease. Age is associated with a slower rate of decrease. To be certain that the INR at the time of the surgery is less than 1.2, warfarin should be withheld for 96 to 115 hours (4 doses) in patients with a steady-state INR between 2.0 and 3.0. For patients with a higher steady-state INR, a longer wait is necessary.

Figures

Grahic Jump Location
Figure 1.
Decrease in the international normalized ratio (INR) over time after discontinuation of warfarin therapy.

The measured INR is depicted as a function of time after the last dose of warfarin.

Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)